| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |